A Randomised, Double-Blind, Parallel Group, Multicentre, Stratified, S
Research payments
$2,428,339
Through program year 2022, $2,428,339 in research payments was reported against A Randomised, Double-Blind, Parallel Group, Multicentre, Stratified, S, across 352 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $208,426 | 33 |
| 2021 | Research | $965,404 | 143 |
| 2020 | Research | $476,351 | 74 |
| 2019 | Research | $778,159 | 102 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ileana Rodicio Miami, FL Named on 18 payments
- Punita Ponda Great Neck, NY Named on 14 payments
- Jaime Landman Miami, FL Named on 14 payments
- Martha Tarpay Oklahoma City, OK Named on 11 payments
- Niran Amar Waco, TX Named on 11 payments
- Lee Clore Owensboro, KY Named on 10 payments
- Rachel Zabaneh Huntington Beach, CA Named on 10 payments
- Joi Lucas Orlando, FL Named on 8 payments
- Kelly Smith New Braunfels, TX Named on 8 payments
- Karen Dunn Raleigh, NC Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.